Titan Pharmaceuticals, Inc.: capex
| Value | {"amount": 26000, "concept": "us-gaap:PaymentsToAcquirePropertyPlantAndEquipment", "currency": "USD"} |
|---|---|
| Period | 2017-01-01 – 2017-03-31 |
| Status | current |
| Entity | Titan Pharmaceuticals, Inc. |
Provenance
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
Retrieved: 2026-08-19T09:08:36.321546+02:00
Raw response sha256:
Also addressable by official identifiers:
Cite as: FACTANKER, https://factanker.com/fact/de7fe661-8d33-49ee-ba72-c7e5165ca0a0
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
0001144204-17-025807 · Open the official SEC filing →Retrieved: 2026-08-19T09:08:36.321546+02:00
Raw response sha256:
f7bde1a401b286c74a2fd824ee1df541…Also addressable by official identifiers:
https://factanker.com/fact/sec/cik-0000910267/capex/2017-03-31 (CIK, metric, reporting date)Cite as: FACTANKER, https://factanker.com/fact/de7fe661-8d33-49ee-ba72-c7e5165ca0a0
History
- no predecessors — first report